12
Participants
Start Date
November 25, 2024
Primary Completion Date
February 28, 2026
Study Completion Date
February 28, 2026
RhPDGF-BB
0.3 mg/mL rhPDGF-BB
RECRUITING
Vanderbilt University Medical Center, Nashville
Lynch Regenerative Medicine, LLC
UNKNOWN
Alexander Hawkins
OTHER